Christopher Desmond to Anti-Retroviral Agents
This is a "connection" page, showing publications Christopher Desmond has written about Anti-Retroviral Agents.
Connection Strength
0,242
-
Is Option B+ the best choice? Authors' reply. Lancet. 2013 Apr 13; 381(9874):1273-4.
Score: 0,077
-
Is Option B+ the best choice? Lancet. 2013 Jan 26; 381(9863):269-71.
Score: 0,076
-
The CombinADO study to assess the impact of a combination intervention strategy on viral suppression, antiretroviral therapy adherence, and retention in HIV care among adolescents and young people living with HIV: protocol for a cluster-randomized controlled trial. Trials. 2021 Dec 27; 22(1):956.
Score: 0,035
-
Characteristics of adolescents aged 15-19 years living with vertically and horizontally acquired HIV in Nampula, Mozambique. PLoS One. 2021; 16(4):e0250218.
Score: 0,034
-
Delivering pediatric HIV care in resource-limited settings: cost considerations in an expanded response. AIDS. 2013 Nov; 27 Suppl 2:S179-86.
Score: 0,020